Skip to main content

Advertisement

Log in

Evolution of virulence-related phenotypes of Sporothrix brasiliensis isolates from patients with chronic sporotrichosis and acquired immunodeficiency syndrome

  • Bacterial and Fungal Pathogenesis - Research Paper
  • Published:
Brazilian Journal of Microbiology Aims and scope Submit manuscript

Abstract

Sporotrichosis in immunocompromised patients has a high morbidity and may cause deaths. Particularly, patients with acquired immunodeficiency syndrome (AIDS) with low T CD4 counts develop a chronic disease, with severe and widespread forms. Recently, the ability of Sporothrix brasiliensis, the main agent of zoonotic sporotrichosis, to increase its virulence in a diabetic patient without HIV infection was described. Since it was a unique finding, it is not known how often this occurs in patients with chronic and refractory sporotrichosis. The aim of this study is to compare sequential Sporothrix isolates obtained from patients with sporotrichosis and AIDS in order to detect changes in virulence-related phenotypes and acquisition of antifungal resistance during the evolution of the disease. Fungal growth in different substrates, antifungal susceptibility, thermotolerance, resistance to oxidative stress, and production of hydrolytic enzymes were evaluated. Correlations were assessed between clinical and phenotypic variables. Sixteen isolates, all identified as S. brasiliensis, obtained from five patients were studied. They grew well on glucose and N-acetyl-D-glucosamine, but poorly on lactate. Except from isolates collected from two patients, which were non-wild type for terbinafine, they were considered wild type for the antifungal drugs tested. Thermotolerance of the isolates was moderate to high. Except for phytase and phospholipase, isolates were able to produce virulence-related enzymes on different levels. Changes in all studied phenotypes were observed during the course of the disease in some patients. The results show that the HIV-driven immunosuppression is more relevant than fungal phenotypes on the unfavorable outcomes of disseminated sporotrichosis.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2
Fig. 3
Fig. 4
Fig. 5
Fig. 6

Similar content being viewed by others

References

  1. Marimon R, Cano J, Gené J, Sutton DA, Kawasaki M, Guarro J (2007) Sporothrix brasiliensis, S. globosa, and S. mexicana, three new Sporothrix species of clinical interest. J Clin Microbiol 45:3198–3206. https://doi.org/10.1128/JCM.00808-07

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  2. Chakrabarti A, Bonifaz A, Gutierrez-Galhardo MC, Mochizuki T, Li S (2015) Global epidemiology of sporotrichosis. Med Mycol 53:3–14. https://doi.org/10.1093/mmy/myu062

    Article  CAS  PubMed  Google Scholar 

  3. Zhang Y, Hagen F, Stielow B, Rodrigues AM, Samerpitak K, Zhou X, Feng P, Yang L, Chen M, Deng S, Li S, Liao W, Li R, Li F, Meis JF, Guarro J, Teixeira M, Al-Zahrani HS, Pires de Camargo Z, Zhang L, de Hoog GS (2015) Phylogeography and evolutionary patterns in Sporothrix spanning more than 14 000 human and animal case reports. Persoonia 35:1–20. https://doi.org/10.3767/003158515X687416

    Article  PubMed  PubMed Central  Google Scholar 

  4. Rodrigues AM, Cruz Choappa R, Fernandes GF, de Hoog GS, de Camargo ZP (2016) Sporothrix chilensis sp. nov. (Ascomycota: Ophiostomatales), a soil-borne agent of human sporotrichosis with mild-pathogenic potential to mammals. Fungal Biol 120:246–264. https://doi.org/10.1016/j.funbio.2015.05.006

    Article  PubMed  Google Scholar 

  5. Orofino-Costa R, de Macedo PM, Rodrigues AM, Bernardes-Engemann AR (2017) Sporotrichosis: an update on epidemiology, etiopathogenesis, laboratory and clinical therapeutics. An Bras Dermatol 92:606–620. https://doi.org/10.1590/abd1806-4841.2017279

    Article  PubMed  PubMed Central  Google Scholar 

  6. Barros MBL, Almeida-Paes R, Schubach AO (2011) Sporothrix schenckii and Sporotrichosis. Clin Microbiol Rev 24:633–654. https://doi.org/10.1128/CMR.00007-11

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  7. Falcão EMM, de Lima Filho JB, Campos DP, Valle ACF, Bastos FI, Gutierrez-Galhardo MC, Freitas DFS (2019) Hospitalizações e mortes relacionadas à esporotricose no Brasil (1992-2015). Cad Saude Publica 35:e00109218. https://doi.org/10.1590/0102-311X00109218

    Article  PubMed  Google Scholar 

  8. Córdoba S, Isla G, Szusz W, Vivot W, Hevia A, Davel G, Canteros CE (2018) Molecular identification and susceptibility profile of Sporothrix schenckii sensu lato isolated in Argentina. Mycoses 61:441–448. https://doi.org/10.1111/myc.12760

    Article  CAS  PubMed  Google Scholar 

  9. Freitas DFS, Santos SS, Almeida-Paes R, Oliveira MME, Valle ACF, Gutierrez-Galhardo MC, Zancopé-Oliveira RM, Nosanchuk JD (2015) Increase in virulence of Sporothrix brasiliensis over five years in a patient with chronic disseminated sporotrichosis. Virulence 6:112–120. https://doi.org/10.1080/21505594.2015.1014274

    Article  PubMed  PubMed Central  Google Scholar 

  10. Steenbergen JN, Nosanchuk JD, Malliaris SD, Casadevall A (2004) Interaction of Blastomyces dermatitidis, Sporothrix schenckii, and Histoplasma capsulatum with Acanthamoeba castellanii. Infect Immun 72:3478–3488. https://doi.org/10.1128/IAI.72.6.3478-3488.2004

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  11. Almeida-Paes R, Brito-Santos F, Oliveira MME, Bailão AM, Borges CL, Araújo GRS, Frases S, CMA S, Zancopé-Oliveira RM (2019) Interaction with Pantoea agglomerans modulates growth and melanization of Sporothrix brasiliensis and Sporothrix schenckii. Mycopathologia 184:367–381. https://doi.org/10.1007/s11046-019-00350-x

    Article  CAS  PubMed  Google Scholar 

  12. Moreira JAS, Freitas DFS, Lamas CC (2015) The impact of sporotrichosis in HIV-infected patients: a systematic review. Infection 43:267–276. https://doi.org/10.1007/s15010-015-0746-1

    Article  PubMed  Google Scholar 

  13. Ramos-e-Silva M, Lima CMO, Schechtman RC, Trope BM, Carneiro S (2012) Systemic mycoses in immunodepressed patients (AIDS). Clin Dermatol 30:616–627. https://doi.org/10.1016/j.clindermatol.2012.01.008

    Article  PubMed  Google Scholar 

  14. Freitas DFS, do ACF V, da Silva MBT, Campos DP, Lyra MR, de Souza RV, Veloso VG, Zancopé-Oliveira RM, Bastos FI, Galhardo MCG (2014) Sporotrichosis: an emerging neglected opportunistic infection in HIV-infected patients in Rio de Janeiro, Brazil. PLoS Negl Trop Dis 8:e3110. https://doi.org/10.1371/journal.pntd.0003110

    Article  PubMed  PubMed Central  Google Scholar 

  15. Brasil. Ministério da Saúde. Departamento de Vigilância, Prevenção e Controle das Infecções Sexualmente Transmissíveis, do HIV/Aids e das Hepatites Virais (2018). Protocolo clínico e diretrizes terapêuticas para manejo da infecção pelo HIV em adultos. Brasília, DF

  16. Almeida-Paes R, Pimenta MA, Pizzini CV, Monteiro PCF, Peralta JM, Nosanchuk JD, Zancopé-Oliveira RM (2007) Use of mycelial-phase Sporothrix schenckii exoantigens in an enzyme-linked immunosorbent assay for diagnosis of sporotrichosis by antibody detection. Clin Vaccine Immunol 14:244–249. https://doi.org/10.1128/CVI.00430-06

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  17. Rodrigues AM, de Hoog GS, de Camargo ZP (2015) Molecular diagnosis of pathogenic Sporothrix species. PLoS Negl Trop Dis 9:e0004190. https://doi.org/10.1371/journal.pntd.0004190

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  18. CLSI - Clinical and Laboratory Standars Institute (2008). Reference method for broth dilution antifungal susceptibility testing of filamentous fungi. Approved standard-second edition ed. Wayne, PA. USA: Clinical and Laboratory Standards Institute

  19. CLSI - Clinical and Laboratory Standars Institute (2012) Reference method for both dilution antifungal susceptibility testing of yeasts. Approved standard-third edition. CLSI DOCUMENT M27-A3. Clinical and Laboratory Standards Institute. Wayne, PA: Clinical and Laboratory Standards Institute

  20. Espinel-Ingroff A, Abreu DPB, Almeida-Paes R, Brilhante RSN, Chakrabarti A, Chowdhary A, Hagen F, Córdoba S, Gonzalez GM, Govender NP, Guarro J, Johnson EM, Kidd SE, Pereira SA, Rodrigues AM, Rozental S, Szeszs MW, Ballesté Alaniz R, Bonifaz A, Bonfietti LX, Borba-Santos LP, Capilla J, Colombo AL, Dolande M, Isla MG, Melhem MSC, Mesa-Arango AC, Oliveira MME, Panizo MM, Pires de Camargo Z, Zancope-Oliveira RM, Meis JF, Turnidge J (2017) Multicenter, international study of MIC/MEC distributions for definition of epidemiological cutoff values for Sporothrix species identified by molecular methods. Antimicrob Agents Chemother 61:e01057–e01017. https://doi.org/10.1128/AAC.01057-17

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  21. Mesa-Arango AC, Del Rocío R-MM, Pérez-Mejía A, Navarro-Barranco H, Souza V, Zúñiga G, Toriello C (2002) Phenotyping and genotyping of Sporothrix schenckii isolates according to geographic origin and clinical form of sporotrichosis. J Clin Microbiol 40:3004–3011. https://doi.org/10.1128/jcm.40.8.3004-3011.2002

    Article  PubMed  PubMed Central  Google Scholar 

  22. Wang Y, Casadevall A (1994) Susceptibility of melanized and nonmelanized Cryptococcus neoformans to nitrogen- and oxygen-derived oxidants. Infect Immun 62:3004–3007

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  23. Almeida-Paes R, de Oliveira LC, Oliveira MME, Gutierrez-Galhardo MC, Nosanchuk JD, Zancopé-Oliveira RM (2015) Phenotypic characteristics associated with virulence of clinical isolates from the Sporothrix complex. Biomed Res Int 2015:212308. https://doi.org/10.1155/2015/212308

    Article  PubMed  PubMed Central  Google Scholar 

  24. Price MF, Wilkinson ID, Gentry LO (1982) Plate method for detection of phospholipase activity in Candida albicans. Sabouraudia 20:7–14. https://doi.org/10.1080/00362178285380031

    Article  CAS  PubMed  Google Scholar 

  25. Tsang PW-K (2011) Differential phytate utilization in Candida species. Mycopathologia 172:473–479. https://doi.org/10.1007/s11046-011-9453-3

    Article  CAS  PubMed  Google Scholar 

  26. Ghannoum MA (2000) Potential role of phospholipases in virulence and fungal pathogenesis. Clin Microbiol Rev 13:122–143. https://doi.org/10.1128/cmr.13.1.122-143.2000

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  27. Aktas E, Yigit N, Ayyildiz A (2002) Esterase activity in various Candida species. J Int Med Res 30:322–324. https://doi.org/10.1177/147323000203000315

    Article  CAS  PubMed  Google Scholar 

  28. Paixão AG, Galhardo MCG, Almeida-Paes R, Nunes EP, Gonçalves MLC, Chequer GL, Lamas CC (2015) The difficult management of disseminated Sporothrix brasiliensis in a patient with advanced AIDS. AIDS Res Ther 12:16. https://doi.org/10.1186/s12981-015-0051-1

    Article  PubMed  PubMed Central  Google Scholar 

  29. Ballard E, Melchers WJG, Zoll J, Brown AJP, Verweij PE, Warris A (2018) In-host microevolution of Aspergillus fumigatus: a phenotypic and genotypic analysis. Fungal Genet Biol 113:1–13. https://doi.org/10.1016/j.fgb.2018.02.003

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  30. Arras SDM, Ormerod KL, Erpf PE, Espinosa MI, Carpenter AC, Blundell RD, Stowasser SR, Schulz BL, Tanurdzic M, Fraser JA (2017) Convergent microevolution of Cryptococcus neoformans hypervirulence in the laboratory and the clinic. Sci Rep 7:17918. https://doi.org/10.1038/s41598-017-18106-2

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  31. Cheng S, Clancy CJ, Zhang Z, Hao B, Wang W, Iczkowski KA, Pfaller MA, Nguyen MH (2007) Uncoupling of oxidative phosphorylation enables Candida albicans to resist killing by phagocytes and persist in tissue. Cell Microbiol 9:492–501. https://doi.org/10.1111/j.1462-5822.2006.00805.x

    Article  CAS  PubMed  Google Scholar 

  32. Chen Y, Farrer RA, Giamberardino C, Sakthikumar S, Jones A, Yang T, Tenor JL, Wagih O, Van Wyk M, Govender NP, Mitchell TG, Litvintseva AP, Cuomo CA, Perfect JR (2017) Microevolution of serial clinical isolates of Cryptococcus neoformans var. grubii and C. gattii. MBio 8:e00166–e00117. https://doi.org/10.1128/mBio.00166-17

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  33. Freitas DFS, Hoagland BS, Valle ACF, Fraga BB, Barros MBL, Schubach AO, Almeida-Paes R, Cuzzi T, Rosalino CMV, Zancopé-Oliveira RM, Gutierrez-Galhardo MC (2012) Sporotrichosis in HIV-infected patients: report of 21 cases of endemic sporotrichosis in Rio de Janeiro, Brazil. Med Mycol 50:170–178. https://doi.org/10.3109/13693786.2011.596288

    Article  PubMed  Google Scholar 

  34. Almeida-Paes R, de Oliveira MME, Freitas DFS, Valle ACF, Zancopé-Oliveira RM, Gutierrez-Galhardo MC (2014) Sporotrichosis in Rio de Janeiro, Brazil: Sporothrix brasiliensis is associated with atypical clinical presentations. PLoS Negl Trop Dis 8:e3094. https://doi.org/10.1371/journal.pntd.0003094

    Article  PubMed  PubMed Central  Google Scholar 

  35. Rodrigues AM, de Hoog GS, Zhang Y, de Camargo ZP (2014) Emerging sporotrichosis is driven by clonal and recombinant Sporothrix species. Emerg Microbes Infect 3:e32. https://doi.org/10.1038/emi.2014.33

    Article  PubMed  PubMed Central  Google Scholar 

  36. Teixeira Mde M, Rodrigues AM, CKM T, de Almeida LGP, Van Diepeningen AD, van den Ende BG, Fernandes GF, Kano R, Hamelin RC, Lopes-Bezerra LM, ATR V, de Hoog S, de Camargo ZP, MSS F (2015) Asexual propagation of a virulent clone complex in a human and feline outbreak of sporotrichosis. Eukaryot Cell 14:158–169. https://doi.org/10.1128/EC.00153-14

    Article  CAS  PubMed  Google Scholar 

  37. Fernandes KE, Brockway A, Haverkamp M, Cuomo CA, van Ogtrop F, Perfect JR, Carter DA (2018) Phenotypic variability correlates with clinical outcome in Cryptococcus isolates obtained from Botswanan HIV/AIDS patients. MBio 9:e02016–e02018. https://doi.org/10.1128/mBio.02016-18

    Article  PubMed  PubMed Central  Google Scholar 

  38. Miramón P, Lorenz MC (2017) A feast for Candida: metabolic plasticity confers an edge for virulence. PLoS Pathog 13:e1006144. https://doi.org/10.1371/journal.ppat.1006144

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  39. Boechat JS, Oliveira MME, Almeida-Paes R, Gremião IDF, Machado ACS, Oliveira RVC, Figueiredo ABF, Rabello VBS, Silva KBL, Zancopé-Oliveira RM, Schubach TMP, Pereira SA (2018) Feline sporotrichosis: associations between clinical-epidemiological profiles and phenotypic-genotypic characteristics of the etiological agents in the Rio de Janeiro epizootic area. Mem Inst Oswaldo Cruz 113:185–196. https://doi.org/10.1590/0074-02760170407

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  40. Almeida-Paes R, Oliveira MME, Freitas DFS, Valle ACF, Gutierrez-Galhardo MC, Zancopé-Oliveira RM (2017) Refractory sporotrichosis due to Sporothrix brasiliensis in humans appears to be unrelated to in vivo resistance. Med Mycol 55:507–517. https://doi.org/10.1093/mmy/myw103

    Article  CAS  PubMed  Google Scholar 

  41. Almeida-Paes R, Brito-Santos F, Figueiredo-Carvalho MHG, Machado ACS, Oliveira MME, Pereira SA, Gutierrez-Galhardo MC, Zancopé-Oliveira RM (2017) Minimal inhibitory concentration distributions and epidemiological cutoff values of five antifungal agents against Sporothrix brasiliensis. Mem Inst Oswaldo Cruz 112:376–381. https://doi.org/10.1590/0074-02760160527

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  42. Sanchotene KO, Brandolt TM, Klafke GB, Poester VR, Xavier MO (2017) In vitro susceptibility of Sporothrix brasiliensis: comparison of yeast and mycelial phases. Med Mycol 55:869–876. https://doi.org/10.1093/mmy/myw143

    Article  CAS  PubMed  Google Scholar 

  43. Trilles L, Fernández-Torres B, Lazéra MS, Wanke B, Schubach AO, Almeida-Paes R, Inza I, Guarro J (2005) In vitro antifungal susceptibilities of Sporothrix schenckii in two growth phases. Antimicrob Agents Chemother 49:3952–3954. https://doi.org/10.1128/AAC.49.9.3952-3954.2005

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  44. Fernandes GF, Do Amaral CC, Sasaki A, Godoy PM, De Camargo ZP (2009) Heterogeneity of proteins expressed by Brazilian Sporothrix schenckii isolates. Med Mycol 47:855–861. https://doi.org/10.3109/13693780802713216

    Article  CAS  PubMed  Google Scholar 

  45. Oliveira DC, de Loreto ÉS, Mario DAN, Lopes PGM, Neves LV, da Rocha MP, Santurio JM, Alves SH (2015) Sporothrix schenckii complex: susceptibilities to combined antifungal agents and characterization of enzymatic profiles. Rev Inst Med Trop Sao Paulo 57:289–294. https://doi.org/10.1590/S0036-46652015000400003

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  46. Mendoza M, Alvarado P, Díaz de Torres E, Lucena L, de Albornoz MC (2005) Physiological comportment and in vivo sensitivity of Sporothrix schenckii isolates maintained for 18 years by two preservation methods. Rev Iberoam Micol 22:151–156. https://doi.org/10.1016/s1130-1406(05)70029-2

    Article  PubMed  Google Scholar 

  47. Valentín-Berríos S, González-Velázquez W, Pérez-Sánchez L, González-Méndez R, Rodríguez-Del Valle N (2009) Cytosolic phospholipase A2: a member of the signalling pathway of a new G protein alpha subunit in Sporothrix schenckii. BMC Microbiol 9:100. https://doi.org/10.1186/1471-2180-9-100

    Article  CAS  PubMed  PubMed Central  Google Scholar 

Download references

Acknowledgments

The authors would like to thank Fiocruz, for the financial support.

Funding

RMZ-O was supported in part by Conselho Nacional de Desenvolvimento Científico e Tecnológico (CNPq 302796/2017-7) and Fundação Carlos Chagas Filho de Amparo à Pesquisa do Estado do Rio de Janeiro (FAPERJ E-26/202.527/2019). RA-P was supported in part by Conselho Nacional de Desenvolvimento Científico e Tecnológico (CNPq 305487/2015-9).

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Rodrigo Almeida-Paes.

Ethics declarations

Conflict of interest

The authors declare that they have no conflict of interest.

Additional information

Responsible Editor: Leila Lopes Bezerra.

Publisher’s note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Electronic supplementary material

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Cruz, I.L.R., Freitas, D.F.S., de Macedo, P.M. et al. Evolution of virulence-related phenotypes of Sporothrix brasiliensis isolates from patients with chronic sporotrichosis and acquired immunodeficiency syndrome. Braz J Microbiol 52, 5–18 (2021). https://doi.org/10.1007/s42770-020-00297-y

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s42770-020-00297-y

Keywords

Navigation